4.6 Review

The Antimicrobial Effect of Cold Atmospheric Plasma against Dental Pathogens-A Systematic Review of In-Vitro Studies

Journal

ANTIBIOTICS-BASEL
Volume 10, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics10020211

Keywords

cold atmospheric plasma; non-thermal plasma; antimicrobial; dentistry; Streptococcus mutans; Enterococcus faecalis; Candida albicans; periodontal disease; peri-implant disease; in vitro

Ask authors/readers for more resources

This article reviewed 55 in-vitro studies on the antimicrobial effect of cold atmospheric plasma (CAP) on dental pathogens. The results showed a time-dependent increase of the antimicrobial effect of CAP. Although there were differences in the results among studies, clusters could be identified based on the pathogen, working gases, and treatment time intervals. CAP may be a promising alternative for antimicrobial treatment in dentistry, but further research is needed for verification.
Interest in the application of cold atmospheric plasma (CAP) in the medical field has been increasing. Indications in dentistry are surface modifications and antimicrobial interventions. The antimicrobial effect of CAP is mainly attributed to the generation of reactive oxygen and reactive nitrogen species. The aim of this article is to systematically review the available evidence from in-vitro studies on the antimicrobial effect of CAP on dental pathogens. A database search was performed (PubMed, Embase, Scopus). Data concerning the device parameters, experimental set-ups and microbial cultivation were extracted. The quality of the studies was evaluated using a newly designed assessment tool. 55 studies were included (quality score 31-92%). The reduction factors varied strongly among the publications although clusters could be identified between groups of set pathogen, working gases, and treatment time intervals. A time-dependent increase of the antimicrobial effect was observed throughout the studies. CAP may be a promising alternative for antimicrobial treatment in a clinically feasible application time. The introduced standardized protocol is able to compare the outcome and quality of in-vitro studies. Further studies, including multi-species biofilm models, are needed to specify the application parameters of CAP before CAP should be tested in randomized clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available